Latest Retinitis pigmentosa Stories
Usher syndrome (USH), an inherited condition involving both hearing and vision loss, is not a simply recessively inherited disease.
Researchers working toward cure for pigmentosa; other retinal diseases.
TOKYO, June 3 /PRNewswire/ -- We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva (TM), which we are developing as a therapeutic drug for retinitis pigmentosa (note 1), has been completed. Retinitis pigmentosa is an intractable disease where therapeutic drugs or therapeutic methods have not been established yet.
Complex tissue structure â€“ a first â€“ offers hope to millions with degenerative eye disorders.
Honored for innovations that improve vision for visually impaired BOSTON, May 3 /PRNewswire-USNewswire/ -- Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute, has been selected by the Society for Information Display for the Otto Schade Prize.
Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration.
Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.
BONN, Germany, April 6 /PRNewswire/ -- IMI Intelligent Medical Implants, a pioneer developer of a system designed to restore vision to people blinded by diseases such as retinitis pigmentosa or macular degeneration, has named veteran life sciences executive, Robert J.
New research in the FASEB Journal shows that nucleic acid nanoparticle platform delivery technology achieves successful gene transfer and reverses affects of retinitis pigmentosa in mice
Tel Aviv University pioneers research for new retinal implant technology.